← Back to home

Impact of SGLT2-inhibitors on PC-AKI in acs patients receiving invasive strategy

Clinical trials for Impact of SGLT2-inhibitors on PC-AKI in acs patients receiving invasive strategy explained in plain language.

Never miss a new study

Get alerted when new Impact of SGLT2-inhibitors on PC-AKI in acs patients receiving invasive strategy trials appear

Sign up with your email to follow new studies for Impact of SGLT2-inhibitors on PC-AKI in acs patients receiving invasive strategy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Heart patients may get kidney protection from common diabetes pills

Disease control Ongoing

This study looks at whether SGLT-2 inhibitors, a type of diabetes medication, can prevent kidney damage from contrast dye used during heart procedures like angioplasty. Researchers will follow 3,600 adults with acute coronary syndrome who are undergoing invasive treatment. The go…

Matched conditions: IMPACT OF SGLT2-INHIBITORS ON PC-AKI IN ACS PATIENTS RECEIVING INVASIVE STRATEGY

Sponsor: Shenyang Northern Hospital • Aim: Disease control

Last updated Jun 26, 2026 15:27 UTC

Impact of SGLT2-inhibitors on PC-AKI in acs patients receiving invasive strategy

Get alerted when new Impact of SGLT2-inhibitors on PC-AKI in acs patients receiving invasive strategy trials appear

Heart patients may get kidney protection from common diabetes pills